Table 1 Comparison of baseline and outcome data between the training and validation groups.
Variables | All cohort (n=308) | Training group (n=215) | Validation group (n=93) | Statistic | P |
---|---|---|---|---|---|
BMI, kg/m2, Mean ± SD | 25.37 ± 5.84 | 25.35 ± 5.94 | 25.43 ± 5.64 | t=0.10 | 0.917 |
Age, years, Mean ± SD | 65.59 ± 8.06 | 65.87 ± 8.08 | 64.92 ± 7.99 | t=-0.95 | 0.343 |
Systolic blood pressure, mmHg, Mean ± SD | 131.20 ± 16.98 | 131.46 ± 16.69 | 130.61 ± 17.70 | t=-0.40 | 0.690 |
Diastolic blood pressure, mmHg, Mean ± SD | 78.65 ± 12.04 | 79.01 ± 12.32 | 77.82 ± 11.38 | t=-0.80 | 0.426 |
Blood Sugar, mg/dl, Mean ± SD | 98.82 ± 14.63 | 98.57 ± 14.37 | 99.39 ± 15.28 | t=0.45 | 0.654 |
TyG index, Mean ± SD | 8.56 ± 0.54 | 8.55 ± 0.52 | 8.60 ± 0.59 | t=0.77 | 0.443 |
eGFR, M (Q₁, Q₃) | 70.39 (56.10, 84.18) | 70.24 (55.93, 84.54) | 71.56 (58.47, 82.70) | Z=-0.02 | 0.984 |
HDL-C, mmol/L, M (Q₁, Q₃) | 1.29 (1.09, 1.55) | 1.29 (1.11, 1.56) | 1.27 (1.06, 1.50) | Z=-0.93 | 0.351 |
Triglycerides, mg/dl, M (Q₁, Q₃) | 106.00 (75.00, 155.00) | 104.00 (75.00, 155.50) | 112.00 (78.00, 154.00) | Z=-0.43 | 0.666 |
LDL-C, mmol/L, M (Q₁, Q₃) | 110.00 (87.75, 137.00) | 109.00 (88.00, 135.50) | 113.00 (87.00, 139.00) | Z=-0.33 | 0.738 |
Male, n (%) | 203(65.91) | 143(66.51) | 60(64.52) | χ²=0.12 | 0.734 |
History of diabetes, n (%) | 35 (11.36) | 27 (12.56) | 8 (8.60) | χ²=1.01 | 0.315 |
History of high blood pressure, n(%) | 167 (54.22) | 112 (52.09) | 55 (59.14) | χ²=1.30 | 0.254 |
Emergency cranial surgery, n (%) | 120 (38.96) | 82 (38.14) | 38 (40.86) | χ²=0.20 | 0.653 |
Preventive heparin therapy, n (%) | 171 (55.52) | 116 (53.95) | 55 (59.14) | χ²=0.71 | 0.400 |
Caprini≥10, n (%) | 257 (84.26) | 179 (84.04) | 78 (84.78) | χ²=0.03 | 0.870 |
Smoking history, n (%) | 167 (54.22) | 115 (53.49) | 52 (55.91) | χ²=0.15 | 0.695 |
Drinking history, n (%) | 186 (60.39) | 129 (60.00) | 57 (61.29) | χ²=0.05 | 0.832 |
With pneumonia, n (%) | 62 (20.13) | 43 (20.00) | 19 (20.43) | χ²=0.01 | 0.931 |
History of stroke, n (%) | 18 (5.84) | 11 (5.12) | 7 (7.53) | χ²=0.69 | 0.408 |
Lower extremity venous thrombosis, n (%) | 94 (30.52) | 64 (29.77) | 30 (32.26) | χ²=0.19 | 0.663 |